Exscien Corporation's Grant

Exscien Corporation raised a round of funding on August 16, 2017. Investors include National Heart Lung and Blood Institute.

Exscien Corporation develops protein technologies that address the consequences resulting from Reactive Oxygen Species (ROS) induced damage.…

Articles about Exscien Corporation's Grant: